BRAINLIFE.ORG




Current Neuro-Oncology




Volume 1 Supplement 3
31 December 1999




Home > Publications > Current Neuro-Oncology > Volume 1, Year 1999 > Supplement 3, 31 December






Literature selection: 1995 – 1998





Finlay JL, Boyett JM, Yates AJ, Wisoff JH, Milstein JM, Geyer JR, Bertolone SJ, McGuire P, Cherlow JM, Tefft M, et al.
Randomized phase III trial in childhood high-grade astrocytoma comparing vincristine, lomustine, and prednisone with the eight-drugs-in-1-day regimen. Childrens Cancer Group.
J Clin Oncol. 1995 Jan 1;13(1):112-23
. doi: 10.1200/JCO.1995.13.1.112. PMID: 7799011. Interventional study.



Janss AJ, Grundy R, Cnaan A, Savino PJ, Packer RJ, Zackai EH, Goldwein JW, Sutton LN, Radcliffe J, Molloy PT, et al.
Optic pathway and hypothalamic/chiasmatic gliomas in children younger than age 5 years with a 6-year follow-up.
Cancer. 1995 Feb 15;75(4):1051-9
. doi: 10.1002/1097-0142(19950215)75:4<1051::aid-cncr2820750423>3.0.co;2-s. PMID: 7842408. Observational study.



Pollack IF, Claassen D, al-Shboul Q, Janosky JE, Deutsch M.
Low-grade gliomas of the cerebral hemispheres in children: an analysis of 71 cases.
J Neurosurg. 1995 Apr;82(4):536-47
. doi: 10.3171/jns.1995.82.4.0536. PMID: 7897512. Observational study.



Wellenreuther R, Kraus JA, Lenartz D, Menon AG, Schramm J, Louis DN, Ramesh V, Gusella JF, Wiestler OD, von Deimling A.
Analysis of the neurofibromatosis 2 gene reveals molecular variants of meningioma.
Am J Pathol. 1995 Apr;146(4):827-32
. PMID: 7717450. Laboratory investigation.



Brem H, Piantadosi S, Burger PC, Walker M, Selker R, Vick NA, Black K, Sisti M, Brem S, Mohr G, Muller P, Morawetz R, Schold SC.
Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. The Polymer-brain Tumor Treatment Group.
Lancet. 1995 Apr 22;345(8956):1008-12
. doi: 10.1016/s0140-6736(95)90755-6. PMID: 7723496. Interventional study.



Zorludemir S, Scheithauer BW, Hirose T, Van Houten C, Miller G, Meyer FB.
Clear cell meningioma. A clinicopathologic study of a potentially aggressive variant of meningioma.
Am J Surg Pathol. 1995 May 1;19(5):493-505
. doi: 10.1097/00000478-199505000-00001. PMID: 7726360. Laboratory investigation.




Shen F, Decosterd LA, Gander M, Leyvraz S, Biollax J, Lejeune F.
Determination of temozolomide in human plasma and urine by high-performance liquid chromatography after solid-phase extraction.
J Chromatogr B Biomed Appl. 1995 May 19;667(2):291-300
. doi: 10.1016/0378-4347(95)00040-p. PMID: 7663702. Laboratory investigation.




Friedman HS, Dolan ME, Pegg AE, Marcelli S, Keir S, Catino JJ, Bigner DD, Schold SC Jr.
Activity of temozolomide in the treatment of central nervous system tumor xenografts.
Cancer Res. 1995 Jul 1;55(13):2853-7
. PMID: 7796412. Laboratory investigation.



Bailey CC, Gnekow A, Wellek S, Jones M, Round C, Brown J, Phillips A, Neidhardt MK.
Prospective randomised trial of chemotherapy given before radiotherapy in childhood medulloblastoma. International Society of Paediatric Oncology (SIOP) and the (German) Society of Paediatric Oncology (GPO): SIOP II.
Med Pediatr Oncol. 1995 Sep;25(3):166-78
. doi: 10.1002/mpo.2950250303. PMID: 7623725. Interventional study.



Sutton LN, Molloy PT, Sernyak H, Goldwein J, Phillips PL, Rorke LB, Moshang T Jr, Lange B, Packer RJ.
Long-term outcome of hypothalamic/chiasmatic astrocytomas in children treated with conservative surgery.
J Neurosurg. 1995 Oct;83(4):583-9
. doi: 10.3171/jns.1995.83.4.0583. PMID: 7674005. Observational study.



Simon M, von Deimling A, Larson JJ, Wellenreuther R, Kaskel P, Waha A, Warnick RE, Tew JM Jr, Menon AG.
Allelic losses on chromosomes 14, 10, and 1 in atypical and malignant meningiomas: a genetic model of meningioma progression.
Cancer Res. 1995 Oct 15;55(20):4696-701
. PMID: 7553651. Laboratory investigation.



Elexpuru-Camiruaga J, Buxton N, Kandula V, Dias PS, Campbell D, McIntosh J, Broome J, Jones P, Inskip A, Alldersea J, et al.
Susceptibility to astrocytoma and meningioma: influence of allelism at glutathione S-transferase (GSTT1 and GSTM1) and cytochrome P-450 (CYP2D6) loci.
Cancer Res. 1995 Oct 1;55(19):4237-9
. PMID: 7671227. Laboratory investigation.



Couldwell WT, Fukushima T, Giannotta SL, Weiss MH.
Petroclival meningiomas: surgical experience in 109 cases.
J Neurosurg. 1996 Jan;84(1):20-8
. doi: 10.3171/jns.1996.84.1.0020. PMID: 8613831. Observational study.



Albright AL, Wisoff JH, Zeltzer PM, Boyett JM, Rorke LB, Stanley P.
Effects of medulloblastoma resections on outcome in children: a report from the Children's Cancer Group.
Neurosurgery. 1996 Feb 1;38(2):265-71
. doi: 10.1097/00006123-199602000-00007. PMID: 8869053. Observational study.



Milosevic MF, Frost PJ, Laperriere NJ, Wong CS, Simpson WJ.
Radiotherapy for atypical or malignant intracranial meningioma.
Int J Radiat Oncol Biol Phys. 1996 Mar 1;34(4):817-22
. doi: 10.1016/0360-3016(95)02166-3. PMID: 8598358. Observational study.




Bobola MS, Tseng SH, Blank A, Berger MS, Silber JR.
Role of O6-methylguanine-DNA methyltransferase in resistance of human brain tumor cell lines to the clinically relevant methylating agents temozolomide and streptozotocin.
Clin Cancer Res. 1996 Apr;2(4):735-41
. PMID: 9816224. Laboratory investigation.




Devineni D, Klein-Szanto A, Gallo JM.
Uptake of temozolomide in a rat glioma model in the presence and absence of the angiogenesis inhibitor TNP-470.
Cancer Res. 1996 May 1;56(9):1983-7
. PMID: 8616836. Laboratory investigation.




Wedge SR, Newlands ES.
O6-benzylguanine enhances the sensitivity of a glioma xenograft with low O6-alkylguanine-DNA alkyltransferase activity to temozolomide and BCNU.
Br J Cancer. 1996 May 1;73(9):1049-52
. doi: 10.1038/bjc.1996.203. PMID: 8624262. Laboratory investigation.




Horwitz NH.
Harvey Cushing (1869-1939).
Neurosurgery. 1996 Jul;39(1):205-9. doi: 10.1097/00006123-199607000-00050. PMID: 8805162. Historical perspective.



Mathiesen T, Lindquist C, Kihlström L, Karlsson B.
Recurrence of cranial base meningiomas.
Neurosurgery. 1996 Jul 1;39(1):2-7
. doi: 10.1097/00006123-199607000-00002. PMID: 8805134. Observational study.



Carneiro SS, Scheithauer BW, Nascimento AG, Hirose T, Davis DH.
Solitary fibrous tumor of the meninges: a lesion distinct from fibrous meningioma. A clinicopathologic and immunohistochemical study.
Am J Clin Pathol. 1996 Aug 1;106(2):217-24
. doi: 10.1093/ajcp/106.2.217. PMID: 8712177. Case report.



Scerrati M, Roselli R, Iacoangeli M, Pompucci A, Rossi GF.
Prognostic factors in low grade (WHO grade II) gliomas of the cerebral hemispheres: the role of surgery.
J Neurol Neurosurg Psychiatry. 1996 Sep 1;61(3):291-6
. doi: 10.1136/jnnp.61.3.291. PMID: 8795601. Observational study.



Karim AB, Maat B, Hatlevoll R, Menten J, Rutten EH, Thomas DG, Mascarenhas F, Horiot JC, Parvinen LM, van Reijn M, Jager JJ, Fabrini MG, van Alphen AM, Hamers HP, Gaspar L, Noordman E, Pierart M, van Glabbeke M.
A randomized trial on dose-response in radiation therapy of low-grade cerebral glioma: European Organization for Research and Treatment of Cancer (EORTC) Study 22844.
Int J Radiat Oncol Biol Phys. 1996 Oct 1;36(3):549-56
. doi: 10.1016/s0360-3016(96)00352-5. PMID: 8948338. Interventional study.



De Jesús O, Sekhar LN, Parikh HK, Wright DC, Wagner DP.
Long-term follow-up of patients with meningiomas involving the cavernous sinus: recurrence, progression, and quality of life.
Neurosurgery. 1996 Nov 1;39(5):915-9
. doi: 10.1097/00006123-199611000-00005. PMID: 8905745. Observational study.




Newlands ES, O'Reilly SM, Glaser MG, Bower M, Evans H, Brock C, Brampton MH, Colquhoun I, Lewis P, Rice-Edwards JM, Illingworth RD, Richards PG.
The Charing Cross Hospital experience with temozolomide in patients with gliomas.
Eur J Cancer. 1996 Dec 1;32A(13):2236-41
. doi: 10.1016/s0959-8049(96)00258-4. PMID: 9038604. Observational study.



Hsu DW, Efird JT, Hedley-Whyte ET.
Progesterone and estrogen receptors in meningiomas: prognostic considerations.
J Neurosurg. 1997 Jan;86(1):113-20
. doi: 10.3171/jns.1997.86.1.0113. PMID: 8988089. Observational study.




Wedge SR, Porteous JK, Glaser MG, Marcus K, Newlands ES.
In vitro evaluation of temozolomide combined with X-irradiation.
Anticancer Drugs. 1997 Jan;8(1):92-7
. doi: 10.1097/00001813-199701000-00013. PMID: 9147618. Laboratory investigation.



Gaspar L, Scott C, Rotman M, Asbell S, Phillips T, Wasserman T, McKenna WG, Byhardt R.
Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials.
Int J Radiat Oncol Biol Phys. 1997 Mar 1;37(4):745-51
. doi: 10.1016/s0360-3016(96)00619-0. PMID: 9128946. Observational study.



Saas P, Walker PR, Hahne M, Quiquerez AL, Schnuriger V, Perrin G, French L, Van Meir EG, de Tribolet N, Tschopp J, Dietrich PY.
Fas ligand expression by astrocytoma in vivo: maintaining immune privilege in the brain?
J Clin Invest. 1997 Mar 15;99(6):1173-8
. doi: 10.1172/JCI119273. PMID: 9077524. Laboratory investigation.



Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, Puc J, Miliaresis C, Rodgers L, McCombie R, Bigner SH, Giovanella BC, Ittmann M, Tycko B, Hibshoosh H, Wigler MH, Parsons R.
PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer.
Science. 1997 Mar 28;275(5308):1943-7
. doi: 10.1126/science.275.5308.1943. PMID: 9072974. Laboratory investigation.



Langford LA, Piatyszek MA, Xu R, Schold SC Jr, Wright WE, Shay JW.
Telomerase activity in ordinary meningiomas predicts poor outcome.
Hum Pathol. 1997 Apr;28(4):416-20
. doi: 10.1016/s0046-8177(97)90029-0. PMID: 9104940. Laboratory investigation.



Leighton C, Fisher B, Bauman G, Depiero S, Stitt L, MacDonald D, Cairncross G.
Supratentorial low-grade glioma in adults: an analysis of prognostic factors and timing of radiation.
J Clin Oncol. 1997 Apr 1;15(4):1294-301
. doi: 10.1200/JCO.1997.15.4.1294. PMID: 9193320. Observational study.



Steck PA, Pershouse MA, Jasser SA, Yung WK, Lin H, Ligon AH, Langford LA, Baumgard ML, Hattier T, Davis T, Frye C, Hu R, Swedlund B, Teng DH, Tavtigian SV.
Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers.
Nat Genet. 1997 Apr 1;15(4):356-62
. doi: 10.1038/ng0497-356. PMID: 9090379. Laboratory investigation.



Packer RJ, Ater J, Allen J, Phillips P, Geyer R, Nicholson HS, Jakacki R, Kurczynski E, Needle M, Finlay J, Reaman G, Boyett JM.
Carboplatin and vincristine chemotherapy for children with newly diagnosed progressive low-grade gliomas.
J Neurosurg. 1997 May;86(5):747-54
. doi: 10.3171/jns.1997.86.5.0747. PMID: 9126887. Observational study.



Palma L, Celli P, Franco C, Cervoni L, Cantore G.
Long-term prognosis for atypical and malignant meningiomas: a study of 71 surgical cases.
J Neurosurg. 1997 May;86(5):793-800
. doi: 10.3171/jns.1997.86.5.0793. PMID: 9126894. Observational study.



Prados MD, Edwards MS, Rabbitt J, Lamborn K, Davis RL, Levin VA.
Treatment of pediatric low-grade gliomas with a nitrosourea-based multiagent chemotherapy regimen.
J Neurooncol. 1997 May;32(3):235-41
. doi: 10.1023/a:1005736104205. PMID: 9049885. Interventional study.



Schrell UM, Rittig MG, Anders M, Koch UH, Marschalek R, Kiesewetter F, Fahlbusch R.
Hydroxyurea for treatment of unresectable and recurrent meningiomas. II. Decrease in the size of meningiomas in patients treated with hydroxyurea.
J Neurosurg. 1997 May;86(5):840-4
. doi: 10.3171/jns.1997.86.5.0840. PMID: 9126900. Interventional study.



Provias J, Claffey K, delAguila L, Lau N, Feldkamp M, Guha A.
Meningiomas: role of vascular endothelial growth factor/vascular permeability factor in angiogenesis and peritumoral edema.
Neurosurgery. 1997 May 1;40(5):1016-26
. doi: 10.1097/0006123-199705000-00027. PMID: 9149260. Laboratory investigation.




Dhodapkar M, Rubin J, Reid JM, Burch PA, Pitot HC, Buckner JC, Ames MM, Suman VJ.
Phase I trial of temozolomide (NSC 362856) in patients with advanced cancer.
Clin Cancer Res. 1997 Jul;3(7):1093-100
. PMID: 9815788. Interventional study.




Friedman HS, Johnson SP, Dong Q, Schold SC, Rasheed BK, Bigner SH, Ali-Osman F, Dolan E, Colvin OM, Houghton P, Germain G, Drummond JT, Keir S, Marcelli S, Bigner DD, Modrich P.
Methylator resistance mediated by mismatch repair deficiency in a glioblastoma multiforme xenograft.
Cancer Res. 1997 Jul 1;57(14):2933-6
. PMID: 9230204. Laboratory investigation.



Gilbertson RJ, Perry RH, Kelly PJ, Pearson AD, Lunec J.
Prognostic significance of HER2 and HER4 coexpression in childhood medulloblastoma.
Cancer Res. 1997 Aug 1;57(15):3272-80
. PMID: 9242460. Laboratory investigation.



Goodrich LV, Milenković L, Higgins KM, Scott MP.
Altered neural cell fates and medulloblastoma in mouse patched mutants.
Science. 1997 Aug 22;277(5329):1109-13
. doi: 10.1126/science.277.5329.1109. PMID: 9262482. Laboratory investigation.




Bower M, Newlands ES, Bleehen NM, Brada M, Begent RJ, Calvert H, Colquhoun I, Lewis P, Brampton MH.
Multicentre CRC phase II trial of temozolomide in recurrent or progressive high-grade glioma.
Cancer Chemother Pharmacol. 1997 Sep;40(6):484-8
. doi: 10.1007/s002800050691. PMID: 9332462. Interventional study



Condra KS, Buatti JM, Mendenhall WM, Friedman WA, Marcus RB Jr, Rhoton AL.
Benign meningiomas: primary treatment selection affects survival.
Int J Radiat Oncol Biol Phys. 1997 Sep 1;39(2):427-36
. doi: 10.1016/s0360-3016(97)00317-9. PMID: 9308947. Observational study.



Lote K, Egeland T, Hager B, Stenwig B, Skullerud K, Berg-Johnsen J, Storm-Mathisen I, Hirschberg H.
Survival, prognostic factors, and therapeutic efficacy in low-grade glioma: a retrospective study in 379 patients.
J Clin Oncol. 1997 Sep 1;15(9):3129-40
. doi: 10.1200/JCO.1997.15.9.3129. PMID: 9294476. Observational study.



Perry A, Scheithauer BW, Nascimento AG.
The immunophenotypic spectrum of meningeal hemangiopericytoma: a comparison with fibrous meningioma and solitary fibrous tumor of meninges.
Am J Surg Pathol. 1997 Nov;21(11):1354-60
. doi: 10.1097/00000478-199711000-00010. PMID: 9351573. Laboratory investigation˰



Perry A, Stafford SL, Scheithauer BW, Suman VJ, Lohse CM.
Meningioma grading: an analysis of histologic parameters.
Am J Surg Pathol. 1997 Dec;21(12):1455-65
. doi: 10.1097/00000478-199712000-00008. PMID: 9414189. Observational study˰



Weber RG, Boström J, Wolter M, Baudis M, Collins VP, Reifenberger G, Lichter P.
Analysis of genomic alterations in benign, atypical, and anaplastic meningiomas: toward a genetic model of meningioma progression.
Proc Natl Acad Sci USA. 1997 Dec 23;94(26):14719-24
. doi: 10.1073/pnas.94.26.14719. PMID: 9405679. Laboratory investigation.



Boström J, Cobbers JM, Wolter M, Tabatabai G, Weber RG, Lichter P, Collins VP, Reifenberger G.
Mutation of the PTEN (MMAC1) tumor suppressor gene in a subset of glioblastomas but not in meningiomas with loss of chromosome arm 10q.
Cancer Res. 1998 Jan 1;58(1):29-33
. PMID: 9426052. Laboratory investigation.




Moore MJ, Feld R, Hedley D, Oza A, Siu LL.
A phase II study of temozolomide in advanced untreated pancreatic cancer.
Invest New Drugs. 1998 Mar;16(1):77-9
. doi: 10.1023/a:1006043332368. PMID: 9740547. Interventional study.



Hakim R, Alexander E 3rd, Loeffler JS, Shrieve DC, Wen P, Fallon MP, Stieg PE, Black PM.
Results of linear accelerator-based radiosurgery for intracranial meningiomas.
Neurosurgery. 1998 Mar 1;42(3):446-53
. doi: 10.1097/00006123-199803000-00002. PMID: 9526976. Observational study.



Subach BR, Lunsford LD, Kondziolka D, Maitz AH, Flickinger JC.
Management of petroclival meningiomas by stereotactic radiosurgery.
Neurosurgery. 1998 Mar 1;42(3):437-43
. doi: 10.1097/00006123-199803000-00001. PMID: 9526975. Observational study.



Dziuk TW, Woo S, Butler EB, Thornby J, Grossman R, Dennis WS, Lu H, Carpenter LS, Chiu JK.
Malignant meningioma: an indication for initial aggressive surgery and adjuvant radiotherapy.
J Neurooncol. 1998 Apr;37(2):177-88
. doi: 10.1023/a:1005853720926. PMID: 9524097. Observational study.



Mulhern RK, Kepner JL, Thomas PR, Armstrong FD, Friedman HS, Kun LE.
Neuropsychologic functioning of survivors of childhood medulloblastoma randomized to receive conventional or reduced-dose craniospinal irradiation: a Pediatric Oncology Group study.
J Clin Oncol. 1998 May 1;16(5):1723-8
. doi: 10.1200/JCO.1998.16.5.1723. PMID: 9586884. Interventional study.



van Veelen ML, Avezaat CJ, Kros JM, van Putten W, Vecht C.
Supratentorial low grade astrocytoma: prognostic factors, dedifferentiation, and the issue of early versus late surgery.
J Neurol Neurosurg Psychiatry. 1998 May 1;64(5):581-7
. doi: 10.1136/jnnp.64.5.581. PMID: 9598670. Observational study.



Perry A, Stafford SL, Scheithauer BW, Suman VJ, Lohse CM.
The prognostic significance of MIB-1, p53, and DNA flow cytometry in completely resected primary meningiomas.
Cancer. 1998 Jun 1;82(11):2262-9
. doi: 10.1002/(SICI)1097-0142(19980601)82:11<2262::AID-CNCR23>3.0.CO;2-R. PMID: 9610708. Observational study.




Meikle SR, Matthews JC, Brock CS, Wells P, Harte RJ, Cunningham VJ, Jones T, Price P.
Pharmacokinetic assessment of novel anti-cancer drugs using spectral analysis and positron emission tomography: a feasibility study.
Cancer Chemother Pharmacol. 1998 Jul 1;42(3):183-93
. doi: 10.1007/s002800050804. PMID: 9685053. Observational study.




Ma J, Fei ZL, Klein-Szanto A, Gallo JM.
Modulation of angiogenesis by human glioma xenograft models that differentially express vascular endothelial growth factor.
Clin Exp Metastasis. 1998 Aug;16(6):559-68
. doi: 10.1023/a:1006598419541. PMID: 9872603. Laboratory investigation.



Burger PC, Yu IT, Tihan T, Friedman HS, Strother DR, Kepner JL, Duffner PK, Kun LE, Perlman EJ.
Atypical teratoid/rhabdoid tumor of the central nervous system: a highly malignant tumor of infancy and childhood frequently mistaken for medulloblastoma: a Pediatric Oncology Group study.
Am J Surg Pathol. 1998 Sep;22(9):1083-92
. doi: 10.1097/00000478-199809000-00007. PMID: 9737241. Observational study˰




Estlin EJ, Lashford L, Ablett S, Price L, Gowing R, Gholkar A, Kohler J, Lewis IJ, Morland B, Pinkerton CR, Stevens MC, Mott M, Stevens R, Newell DR, Walker D, Dicks-Mireaux C, McDowell H, Reidenberg P, Statkevich P, Marco A, Batra V, Dugan M, Pearson AD.
Phase I study of temozolomide in paediatric patients with advanced cancer. United Kingdom Children's Cancer Study Group.
Br J Cancer. 1998 Sep 1;78(5):652-61
. doi: 10.1038/bjc.1998.555. PMID: 9744506. Interventional study.



Kondziolka D, Flickinger JC, Perez B.
Judicious resection and/or radiosurgery for parasagittal meningiomas: outcomes from a multicenter review. Gamma Knife Meningioma Study Group.
Neurosurgery. 1998 Sep 1;43(3):405-13
. doi: 10.1097/00006123-199809000-00001. PMID: 9733295. Observational study.




Marzolini C, Decosterd LA, Shen F, Gander M, Leyvraz S, Bauer J, Buclin T, Biollaz J, Lejeune F.
Pharmacokinetics of temozolomide in association with fotemustine in malignant melanoma and malignant glioma patients: comparison of oral, intravenous, and hepatic intra-arterial administration.
Cancer Chemother Pharmacol. 1998 Oct;42(6):433-40
. doi: 10.1007/s002800050842. PMID: 9788568. Observational study.




Brock CS, Newlands ES, Wedge SR, Bower M, Evans H, Colquhoun I, Roddie M, Glaser M, Brampton MH, Rustin GJ.
Phase I trial of temozolomide using an extended continuous oral schedule.
Cancer Res. 1998 Oct 1;58(19):4363-7
. PMID: 9766665. Interventional study.



Stafford SL, Perry A, Suman VJ, Meyer FB, Scheithauer BW, Lohse CM, Shaw EG.
Primarily resected meningiomas: outcome and prognostic factors in 581 Mayo Clinic patients, 1978 through 1988.
Mayo Clin Proc. 1998 Oct 1;73(10):936-42
. doi: 10.4065/73.10.936. PMID: 9787740. Observational study.



Cairncross JG, Ueki K, Zlatescu MC, Lisle DK, Finkelstein DM, Hammond RR, Silver JS, Stark PC, Macdonald DR, Ino Y, Ramsay DA, Louis DN.
Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas.
J Natl Cancer Inst. 1998 Oct 7;90(19):1473-9
. doi: 10.1093/jnci/90.19.1473. PMID: 9776413. Observational study.



Patchell RA, Tibbs PA, Regine WF, Dempsey RJ, Mohiuddin M, Kryscio RJ, Markesbery WR, Foon KA, Young B.
Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial.
JAMA. 1998 Nov 4;280(17):1485-9
. doi: 10.1001/jama.280.17.1485. PMID: 9809728. Interventional study.



*

Friedman HS, McLendon RE, Kerby T, Dugan M, Bigner SH, Henry AJ, Ashley DM, Krischer J, Lovell S, Rasheed K, Marchev F, Seman AJ, Cokgor I, Rich J, Stewart E, Colvin OM, Provenzale JM, Bigner DD, Haglund MM, Friedman AH, Modrich PL.
DNA mismatch repair and O6-alkylguanine-DNA alkyltransferase analysis and response to Temodal in newly diagnosed malignant glioma.
J Clin Oncol. 1998 Dec 1;16(12):3851-7
. doi: 10.1200/JCO.1998.16.12.3851. PMID: 9850030. Interventional study.